These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 29969750

  • 1. Higher sympathetic activity as a risk factor for skeletal deterioration in pheochromocytoma.
    Kim BJ, Kwak MK, Kim JS, Lee SH, Koh JM.
    Bone; 2018 Nov; 116():1-7. PubMed ID: 29969750
    [Abstract] [Full Text] [Related]

  • 2. Lower Bone Mass and Higher Bone Resorption in Pheochromocytoma: Importance of Sympathetic Activity on Human Bone.
    Kim BJ, Kwak MK, Ahn SH, Kim H, Lee SH, Song KH, Suh S, Kim JH, Koh JM.
    J Clin Endocrinol Metab; 2017 Aug 01; 102(8):2711-2718. PubMed ID: 28582552
    [Abstract] [Full Text] [Related]

  • 3. Lower Trabecular Bone Score in Patients With Primary Aldosteronism: Human Skeletal Deterioration by Aldosterone Excess.
    Kim BJ, Kwak MK, Ahn SH, Kim H, Lee SH, Koh JM.
    J Clin Endocrinol Metab; 2018 Feb 01; 103(2):615-621. PubMed ID: 29126119
    [Abstract] [Full Text] [Related]

  • 4. Deteriorated bone microarchitecture caused by sympathetic overstimulation in pheochromocytoma and paraganglioma.
    Qi W, Cui L, Jiajue R, Pang Q, Chi Y, Liu W, Jiang Y, Wang O, Li M, Xing X, Tong A, Xia W.
    J Endocrinol Invest; 2024 Apr 01; 47(4):843-856. PubMed ID: 37872466
    [Abstract] [Full Text] [Related]

  • 5. Change of skeletal muscle mass in patients with pheochromocytoma.
    Lee SH, Kwak MK, Ahn SH, Kim H, Cho YY, Suh S, Song KH, Koh JM, Kim JH, Kim BJ.
    J Bone Miner Metab; 2019 Jul 01; 37(4):694-702. PubMed ID: 30238430
    [Abstract] [Full Text] [Related]

  • 6. Different values of urinary fractionated metanephrines after unilateral adrenalectomy for pheochromocytoma according to time intervals after surgery.
    Cho YY, Kim YN, Kim JH, Jeong BC, Lee SY, Kim JH.
    Ann Clin Biochem; 2017 Jan 01; 54(1):165-169. PubMed ID: 26586850
    [Abstract] [Full Text] [Related]

  • 7. Plasma and urinary metanephrines determined by an enzyme immunoassay, but not serum chromogranin A for the diagnosis of pheochromocytoma in patients with adrenal mass.
    Unger N, Hinrichs J, Deutschbein T, Schmidt H, Walz MK, Mann K, Petersenn S.
    Exp Clin Endocrinol Diabetes; 2012 Sep 01; 120(8):494-500. PubMed ID: 22696168
    [Abstract] [Full Text] [Related]

  • 8. Role of deteriorated bone quality in the development of osteoporosis in pheochromocytoma and paraganglioma.
    Yokomoto-Umakoshi M, Umakoshi H, Sakamoto R, Fukumoto T, Ogata M, Nakano Y, Iwahashi N, Kaneko H, Mizoguchi N, Hattori A, Miyazawa T, Matsuda Y, Kawate H, Ogawa Y, Q-AND-A study group.
    Bone; 2021 Jan 01; 142():115607. PubMed ID: 32829039
    [Abstract] [Full Text] [Related]

  • 9. The association of cortisol and adrenal androgen with trabecular bone score in patients with adrenal incidentaloma with and without autonomous cortisol secretion.
    Kim BJ, Kwak MK, Ahn SH, Kim JS, Lee SH, Koh JM.
    Osteoporos Int; 2018 Oct 01; 29(10):2299-2307. PubMed ID: 29971455
    [Abstract] [Full Text] [Related]

  • 10. Adrenal incidentaloma: review of 197 patients and report of a drug-related false-positive urinary normetanephrine result.
    Ito T, Imai T, Kikumori T, Shibata A, Horiba T, Kobayashi H, Sawaki M, Watanabe R, Nakao A, Kiuchi T.
    Surg Today; 2006 Oct 01; 36(11):961-5. PubMed ID: 17072715
    [Abstract] [Full Text] [Related]

  • 11. Impact of Pheochromocytoma or Paraganglioma on Bone Metabolism: A Systemic Review and Meta-analysis.
    Dutta D, Nagendra L, Chandran M, Sharma M, Bhattacharya S, Mukhopadhyay S.
    J Clin Densitom; 2024 Oct 01; 27(3):101501. PubMed ID: 38796986
    [Abstract] [Full Text] [Related]

  • 12. Bone quality, as measured by trabecular bone score in patients with adrenal incidentalomas with and without subclinical hypercortisolism.
    Eller-Vainicher C, Morelli V, Ulivieri FM, Palmieri S, Zhukouskaya VV, Cairoli E, Pino R, Naccarato A, Scillitani A, Beck-Peccoz P, Chiodini I.
    J Bone Miner Res; 2012 Oct 01; 27(10):2223-30. PubMed ID: 22549969
    [Abstract] [Full Text] [Related]

  • 13. [Diagnostic difficulties in recognizing of pheochromocytoma].
    Przybylik-Mazurek E, Buziak-Bereza M, Stochmal E, Budzyński A, Białas M, Kostecka-Matyja M, Hubalewska-Dydejczyk A.
    Przegl Lek; 2010 Oct 01; 67(12):1276-81. PubMed ID: 21591353
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The diagnostic efficacy of urinary fractionated metanephrines measured by tandem mass spectrometry in detection of pheochromocytoma.
    Perry CG, Sawka AM, Singh R, Thabane L, Bajnarek J, Young WF.
    Clin Endocrinol (Oxf); 2007 May 01; 66(5):703-8. PubMed ID: 17388796
    [Abstract] [Full Text] [Related]

  • 16. Urinary normetanephrine and metanephrine measured by radioimmunoassay for the diagnosis of pheochromocytoma: utility of 24-hour and random 1-hour urine determinations.
    Oishi S, Sasaki M, Ohno M, Sato T.
    J Clin Endocrinol Metab; 1988 Sep 01; 67(3):614-8. PubMed ID: 3410942
    [Abstract] [Full Text] [Related]

  • 17. Comparison of plasma metanephrines measured by a commercial immunoassay and urinary catecholamines in the diagnosis of pheochromocytoma.
    Christensen TT, Frystyk J, Poulsen PL.
    Scand J Clin Lab Invest; 2011 Dec 01; 71(8):695-700. PubMed ID: 22023043
    [Abstract] [Full Text] [Related]

  • 18. [Analysis of laboratory data of 155 patients with pheochromocytoma-paraganglioma syndrome diagnosed during the past 20 years].
    Balog B, Tőke J, Róna K, Szücs N, Igaz P, Pusztai P, Sármán B, Gláz E, Kiss R, Patócs A, Rácz K, Tóth M.
    Orv Hetil; 2015 Apr 19; 156(16):626-35. PubMed ID: 25864138
    [Abstract] [Full Text] [Related]

  • 19. Effects of salmon calcitonin on trabecular microarchitecture as determined by magnetic resonance imaging: results from the QUEST study.
    Chesnut CH, Majumdar S, Newitt DC, Shields A, Van Pelt J, Laschansky E, Azria M, Kriegman A, Olson M, Eriksen EF, Mindeholm L.
    J Bone Miner Res; 2005 Sep 19; 20(9):1548-61. PubMed ID: 16059627
    [Abstract] [Full Text] [Related]

  • 20. Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial.
    Bilezikian JP, Hattersley G, Fitzpatrick LA, Harris AG, Shevroja E, Banks K, Leder BZ, Zanchetta JR, Hans D.
    Osteoporos Int; 2018 Feb 19; 29(2):323-328. PubMed ID: 29167971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.